Get started
Work

Pharmacometrics: Opportunity for Reducing Disease Burden in the Developing World: The Case of Africa

Year: 2013
Type: article
Abstract: Pharmacometricians are virtually nonexistent in Africa and the developing world. The unrelenting burden of infectious diseases, which are often treated using medicines with narrow effectiveness and safety dose ranges, and the growing prevalence and recognition of non-communicable diseases represent significant threats for the patients, although affording an opportunity for advancing science. This article outlines the case for pharmacometricians to redirect their expertise to focus on the disease burden affecting the developing world.CPT: Pharmacometrics & Systems Pharmacology (2013) 2, e69; doi:10.1038/psp.2013.45; published online 28 August 2013.
DOI: 10.1038/psp.2013.45
Authors: G Pillai, G Davies, P Denti, J‐L Steimer, H McIlleron, S Zvada, E Chigutsa, E Ngaimisi, F Mirza, B Tadmor, NHG Holford
Institutions: Novartis (Switzerland), University of Liverpool, Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Cape Town, Institute of Infectious Disease and Molecular Medicine, Muhimbili University of Health and Allied Sciences, University of Auckland
Language: English
Field: Medicine
Open Access status: gold
Estimated APC paid: $4,140
Award: G76681233
OpenAlex ID: W2065271929
FWCI: 1.861
Cites: 11
Cited by: 27
Related to: 10